Mergers and acquisitions grabbed the spotlight in the biotech sector this week after Jazz Pharmaceuticals announced ... Shares of Moderna gained after a couple of SEC filings showed that two ...

Shares of the American pharmaceutical company Moderna (MRNA) climbed over 8% in pre-market trading following strategic insider stock purchases ...

HHS cites need for review due to 'oversight' issues CDC states low risk of H5 bird flu to public Moderna's shares drop 5.5% Feb 26 (Reuters) - U.S. health officials are reevaluating a $590 million ...

Klinger joined the Cambridge, Massachusetts-based pharmaceutical company in 2021, when Moderna's stock was trading at around ...

Contract Development and Manufacturing Organizations (CDMOs) enhance drug discovery by providing essential services that reduce costs and accelerate production.

In a report released yesterday, Luca Issi from RBC Capital maintained a Hold rating on Sangamo Biosciences (SGMO – Research Report), with a ...

Shares of clinical-stage biotech Chimerix skyrocketed following an acquisition agreement from Jazz Pharmaceuticals for ... Shares of Moderna gained after a couple of SEC filings showed that ...

Moderna recently experienced a notable 10% price increase over the last week amidst significant legal and financial developments. Genevant Sciences and Arbutus Biopharma have expanded their patent ...

Moderna's shockingly low valuation and robust pipeline are attractive features. An enterprise value of around $6 billion puts ...

The pharmaceutical company said, “The allegations that came out in the media are entirely baseless, distorted, and part of a smear campaign" ...

Fintel reports that on March 13, 2025, Citigroup initiated coverage of Moderna (NasdaqGS:MRNA) with a Neutral recommendation.